Share

June 01, 1965; 15 (6) Article

The rate of recovery of reversible myopathies and the effects of anabolic agents in steroid myopathy

E. N. Coomes
First published June 1, 1965, DOI: https://doi.org/10.1212/WNL.15.6.523
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1455

Share

Article Information

vol. 15 no. 6 523
DOI: 
https://doi.org/10.1212/WNL.15.6.523
PubMed: 
14312774
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
Copyright & Usage: 
© 1965 by the American Academy of Neurology

Author Disclosures

    Article usage

    Article usage: August 2007 to August 2023

    AbstractFullPdfSource
    Aug 2007001Highwire
    Oct 2007001Highwire
    May 2008001Highwire
    Aug 2009001Highwire
    Jun 2013300Highwire
    Jul 2013100Highwire
    Aug 2013400Highwire
    Sep 2013400Highwire
    Oct 2013201Highwire
    Nov 2013300Highwire
    Dec 2013301Highwire
    Jan 2014400Highwire
    Feb 2014100Highwire
    Mar 2014300Highwire
    Apr 2014300Highwire
    May 2014200Highwire
    Jun 2014300Highwire
    Aug 2014201Highwire
    Sep 2014100Highwire
    Oct 2014200Highwire
    Nov 2014200Highwire
    Dec 2014500Highwire
    Jan 2015400Highwire
    Feb 2015200Highwire
    Mar 2015200Highwire
    Apr 2015100Highwire
    May 2015400Highwire
    Jun 2015100Highwire
    Jul 2015201Highwire
    Aug 2015101Highwire
    Sep 2015300Highwire
    Oct 2015802Highwire
    Nov 2015500Highwire
    Dec 2015800Highwire
    Jan 2016301Highwire
    Feb 20161800Highwire
    Mar 20162100Highwire
    Apr 20161300Highwire
    May 20161400Highwire
    Jun 2016600Highwire
    Jul 2016700Highwire
    Aug 20161500Highwire
    Sep 20161200Highwire
    Oct 20161800Highwire
    Nov 20161800Highwire
    Dec 20161600Highwire
    Jan 20171300Highwire
    Feb 20173400Highwire
    Mar 20175200Highwire
    Apr 20173200Highwire
    May 20173101Highwire
    Jun 20172000Highwire
    Jul 20172600Highwire
    Aug 20172500Highwire
    Sep 20173000Highwire
    Oct 20172300Highwire
    Nov 20172101Highwire
    Dec 20170024Highwire
    Jan 20180023Highwire
    Feb 20180016Highwire
    Mar 20180021Highwire
    Apr 20180026Highwire
    May 20180027Highwire
    Jun 20180035Highwire
    Jul 20180019Highwire
    Aug 20180030Highwire
    Sep 20180023Highwire
    Oct 20180024Highwire
    Nov 20180019Highwire
    Dec 20180020Highwire
    Jan 20190020Highwire
    Feb 20190018Highwire
    Mar 20190017Highwire
    Apr 20190020Highwire
    May 20190029Highwire
    Jun 20190032Highwire
    Jul 20190022Highwire
    Aug 20190033Highwire
    Sep 20190033Highwire
    Oct 20190026Highwire
    Nov 20190024Highwire
    Dec 20190021Highwire
    Jan 20200026Highwire
    Feb 20200022Highwire
    Mar 20200018Highwire
    Apr 20200020Highwire
    May 20200021Highwire
    Jun 20200012Highwire
    Jul 20200032Highwire
    Aug 20200018Highwire
    Sep 20200025Highwire
    Oct 20200039Highwire
    Nov 20200023Highwire
    Dec 20200023Highwire
    Jan 20210013Highwire
    Feb 2021006Highwire
    Mar 20210012Highwire
    Apr 2021003Highwire
    May 2021004Highwire
    Jun 2021005Highwire
    Jul 2021006Highwire
    Aug 2021004Highwire
    Sep 20210023Highwire
    Oct 20210018Highwire
    Nov 20210014Highwire
    Dec 20210012Highwire
    Jan 20220015Highwire
    Feb 20220019Highwire
    Mar 20220013Highwire
    Apr 20220020Highwire
    May 20220024Highwire
    Jun 20220016Highwire
    Jul 20220026Highwire
    Aug 20220021Highwire
    Sep 20220024Highwire
    Oct 20220041Highwire
    Nov 20220029Highwire
    Dec 20220017Highwire
    Jan 20230027Highwire
    Feb 20230011Highwire
    Mar 20230021Highwire
    Apr 20230020Highwire
    May 20230017Highwire
    Jun 20230015Highwire
    Jul 20230033Highwire
    Aug 20230031Highwire

    Letters: Rapid online correspondence

    No comments have been published for this article.
    Comment

    REQUIREMENTS

    You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    Advertisement

    Related Articles

    • No related articles found.

    Alert Me